Overview
Kei Hiraoka practices in Hakodate, Japan. Hiraoka is rated as an Experienced expert by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. Their top areas of expertise are Glioma, Gliomatosis Cerebri, Mediastinitis, and Undifferentiated Pleomorphic Sarcoma.
Their clinical research consists of co-authoring 17 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Undifferentiated Pleomorphic Sarcoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- GliomaHiraoka isAdvanced. Learn about Glioma.
- Gliomatosis CerebriHiraoka isAdvanced. Learn about Gliomatosis Cerebri.
- Experienced
- AstrocytomaHiraoka isExperienced. Learn about Astrocytoma.
- COVID-19Hiraoka isExperienced. Learn about COVID-19.
- GlioblastomaHiraoka isExperienced. Learn about Glioblastoma.
- LeukemiaHiraoka isExperienced. Learn about Leukemia.
- Lung AdenocarcinomaHiraoka isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerHiraoka isExperienced. Learn about Lung Cancer.